Insulinoma

Aarti Mathur, Philip Gorden, Steven K. Libutti

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the diagnosis is established, the insulinoma is preoperatively localized within the pancreas with the goal of surgical excision for cure. This review discusses the historical background, diagnosis, and management of sporadic insulinoma.

Original languageEnglish (US)
Pages (from-to)1105-1121
Number of pages17
JournalSurgical Clinics of North America
Volume89
Issue number5
DOIs
StatePublished - Oct 2009

Fingerprint

Insulinoma
Multiple Endocrine Neoplasia Type 1
Neuroendocrine Tumors
Hypoglycemic Agents
Pancreas
Incidence

Keywords

  • Insulinoma
  • Management
  • Metastatic insulinoma
  • Pancreatic neuroendocrine tumor
  • Surgery

ASJC Scopus subject areas

  • Surgery

Cite this

Mathur, A., Gorden, P., & Libutti, S. K. (2009). Insulinoma. Surgical Clinics of North America, 89(5), 1105-1121. https://doi.org/10.1016/j.suc.2009.06.009

Insulinoma. / Mathur, Aarti; Gorden, Philip; Libutti, Steven K.

In: Surgical Clinics of North America, Vol. 89, No. 5, 10.2009, p. 1105-1121.

Research output: Contribution to journalArticle

Mathur, A, Gorden, P & Libutti, SK 2009, 'Insulinoma', Surgical Clinics of North America, vol. 89, no. 5, pp. 1105-1121. https://doi.org/10.1016/j.suc.2009.06.009
Mathur A, Gorden P, Libutti SK. Insulinoma. Surgical Clinics of North America. 2009 Oct;89(5):1105-1121. https://doi.org/10.1016/j.suc.2009.06.009
Mathur, Aarti ; Gorden, Philip ; Libutti, Steven K. / Insulinoma. In: Surgical Clinics of North America. 2009 ; Vol. 89, No. 5. pp. 1105-1121.
@article{a52bee8ace55471188cbb5f8c9a81458,
title = "Insulinoma",
abstract = "Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the diagnosis is established, the insulinoma is preoperatively localized within the pancreas with the goal of surgical excision for cure. This review discusses the historical background, diagnosis, and management of sporadic insulinoma.",
keywords = "Insulinoma, Management, Metastatic insulinoma, Pancreatic neuroendocrine tumor, Surgery",
author = "Aarti Mathur and Philip Gorden and Libutti, {Steven K.}",
year = "2009",
month = "10",
doi = "10.1016/j.suc.2009.06.009",
language = "English (US)",
volume = "89",
pages = "1105--1121",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Insulinoma

AU - Mathur, Aarti

AU - Gorden, Philip

AU - Libutti, Steven K.

PY - 2009/10

Y1 - 2009/10

N2 - Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the diagnosis is established, the insulinoma is preoperatively localized within the pancreas with the goal of surgical excision for cure. This review discusses the historical background, diagnosis, and management of sporadic insulinoma.

AB - Insulinoma is a rare neuroendocrine tumor with an incidence of 4 per 1 million persons per year, which may occur as a unifocal sporadic event in patients without an inherited syndrome or as a part of multiple endocrine neoplasia type 1. Key neuroglycopenic and hypoglycemic symptoms in conjunction with biochemical proof establish the diagnosis. Once the diagnosis is established, the insulinoma is preoperatively localized within the pancreas with the goal of surgical excision for cure. This review discusses the historical background, diagnosis, and management of sporadic insulinoma.

KW - Insulinoma

KW - Management

KW - Metastatic insulinoma

KW - Pancreatic neuroendocrine tumor

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=70349905093&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349905093&partnerID=8YFLogxK

U2 - 10.1016/j.suc.2009.06.009

DO - 10.1016/j.suc.2009.06.009

M3 - Article

C2 - 19836487

AN - SCOPUS:70349905093

VL - 89

SP - 1105

EP - 1121

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 5

ER -